The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Mar. 05, 2013

Filed:

Nov. 03, 2009
Applicants:

James C. Barrow, Arnold, MD (US);

Mark T. Bilodeau, Harleysville, PA (US);

Christopher D. Cox, Harleysville, PA (US);

John C. Hartnett, Philadelphia, PA (US);

Nathan R. Kett, Franklin, TN (US);

Yiwei LI, Lower Gwynedd, PA (US);

Peter J. Manley, Harleysville, PA (US);

Jeffrey Melamed, North Wales, PA (US);

William D. Shipe, Chalfont, PA (US);

B. Wesley Trotter, Newton Highlands, MA (US);

Amy Zartman, Philadelphia, PA (US);

Inventors:

James C. Barrow, Arnold, MD (US);

Mark T. Bilodeau, Harleysville, PA (US);

Christopher D. Cox, Harleysville, PA (US);

John C. Hartnett, Philadelphia, PA (US);

Nathan R. Kett, Franklin, TN (US);

Yiwei Li, Lower Gwynedd, PA (US);

Peter J. Manley, Harleysville, PA (US);

Jeffrey Melamed, North Wales, PA (US);

William D. Shipe, Chalfont, PA (US);

B. Wesley Trotter, Newton Highlands, MA (US);

Amy Zartman, Philadelphia, PA (US);

Assignee:

Merck Sharp & Dohme Corp., Rahway, NJ (US);

Attorneys:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 31/551 (2006.01); A61K 31/5355 (2006.01); A61K 31/497 (2006.01); A61K 31/519 (2006.01); A61K 31/4412 (2006.01); A61K 31/4704 (2006.01); C07D 243/08 (2006.01); C07D 413/14 (2006.01); C07D 471/04 (2006.01); C07D 401/14 (2006.01); C07D 401/12 (2006.01); C07D 405/14 (2006.01);
U.S. Cl.
CPC ...
Abstract

The present invention is directed to quinolone compounds which are antagonists of neuropeptide S receptors, and which are useful in the treatment or prevention of neurological and psychiatric disorders and diseases in which the neuropeptide S receptor is involved. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which the neuropeptide S receptor is involved.


Find Patent Forward Citations

Loading…